Where anal cancer comes from
Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
Anal cancer has no origin event. It is the predictable result of two older things meeting: a virus that has been with our lineage for millions of years, and a piece of anatomy that is permanently under construction.
What has changed recently is not the biology. It is how many cases there are and how well we can see them.
Related pages: Anal cancer
The bottom line
- Papillomaviruses have co-evolved with vertebrates for a very long time.
- HPV types that infect humans track the history of human populations.
- Transformation zones, where two kinds of lining meet, are where HPV-driven cancers arise.
- Anal cancer incidence has risen in recent decades in several countries.
- How much of the rise in incidence is real and how much is better detection.
- Why HPV-16 in particular is so much more carcinogenic than other high-risk types.
The story, step by step
- 1. An ancient virus ()
- 2. Travelling with us ()
- 3. The vulnerable tissue ()
- 4. Rare, then less rare ()
- 5. Why it was overlooked ()
What the evidence labels mean
Older than humans by far
What happens
Papillomaviruses are not a recent human problem.
What the research shows
- They infect mammals, birds, reptiles and fish, and have been co-evolving with vertebrates for hundreds of millions of years.
- Most are harmless and highly species-specific, causing warts or nothing at all.
- HPV does not cross from animals to people, so the animal papillomaviruses are relatives rather than sources.
- Of more than 200 known human types, only around a dozen are classed as high risk for cancer.
Why it matters
HPV is not an invader that arrived. It is a long-term resident of our lineage, and a small number of its types happen to be dangerous.
What's still uncertain
- The number of recognized HPV types keeps growing as sequencing becomes cheaper.
Read more
- Nobel Prize 2008: Harald zur HausenNonprofit
Next: Travelling with us
Viral lineages and human migration
What happens
The genetic variation within HPV types carries a record of human history.
What the research shows
- Different variant lineages of HPV-16 are associated with different world regions.
- Their distribution broadly parallels the spread of human populations out of Africa, because the virus travelled with the people it infected.
- Some variant lineages appear to carry different cancer risk, which is an active research area.
- This is only possible because transmission is overwhelmingly person to person and lifelong exposure is common.
Why it matters
A virus that spreads by close contact and persists for years ends up recording the movements of its hosts.
What's still uncertain
- How much variant lineage affects individual risk is not established well enough to be clinically useful.
Read more
- Nobel Prize 2008: Harald zur HausenNonprofit
Next: The vulnerable tissue
Why transformation zones
What happens
The cancers HPV causes cluster at particular sites, and the sites have something in common.
What the research shows
- The cervix, the anal canal and the tonsillar crypts all have zones where one type of epithelium meets another.
- At those junctions, cells are actively dividing and remodelling, which is precisely what a virus needing dividing basal cells requires.
- The surface there is thinner and less protected than ordinary skin, so microtrauma exposes basal cells more readily.
- This is why the anal cancer story so closely parallels the cervical cancer story: same virus, same kind of tissue, same sequence.
Why it matters
The anatomy predicts the cancers. If you know where the transformation zones are, you can predict where HPV causes cancer.
What's still uncertain
- Why the oropharynx behaves somewhat differently from the cervix and anus is not fully explained.
Read more
- CDC: HPV and cancerGovernment
- OwieClear: What anal cancer isOwieClear
Next: Rare, then less rare
The incidence trend
What happens
Anal cancer has been uncommon throughout recorded medicine, and the numbers have been moving.
What the research shows
- Incidence has risen in the United States and several other countries over recent decades.
- The rise has been seen in both men and women, including in older women, which is not what most people expect.
- Better recognition and better diagnosis account for part of it. Changes in HPV exposure across generations are thought to account for more.
- Longer survival with HIV means more people live long enough for a slow HPV-driven cancer to develop.
- Vaccinated cohorts have not yet reached the ages where anal cancer appears, so the full effect of vaccination is still ahead.
Why it matters
The most consequential fact in this trend is the last one: the vaccine's effect on anal cancer is largely still in the future.
What's still uncertain
- Separating true increases from improved detection is difficult in cancer registry data.
Read more
- American Cancer Society: Anal cancerNonprofit
- CDC: HPV vaccinationGovernment
Next: Why it was overlooked
A cancer with a disguise
What happens
Anal cancer was not well distinguished historically, and there are structural reasons.
What the research shows
- Its symptoms are the symptoms of haemorrhoids, which are extremely common, so cases were misattributed.
- It was often grouped with rectal cancer, obscuring its distinct biology and distinct treatment.
- The anatomical site carries enough embarrassment that people delay seeking help and clinicians sometimes delay examining.
- Only when the HPV link was established in the 1980s did it become clear this was a different disease from the cancer next door.
Why it matters
A disease that looks like something harmless, in a place people do not want to discuss, is a disease that gets found late.
What's still uncertain
- Historical incidence cannot be reliably reconstructed because of this misclassification.